Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT05784688	TitleStudy of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors	Fase Phase 1, Phase 2	Date Added 2023-03-27	Ubicación Texas, United States Washington, United States Corea, República de	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas TU2218 + Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT05838768	TitleStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.	Fase Fase 1	Date Added 2023-05-03	Ubicación California, United States Massachusetts, United States New York, United States Texas, United States Bélgica China Francia Alemania Israel Italia Japón Corea, República de Noruega Singapur España Suecia Taiwán Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas HRO761, Irinotecan	Etiquetas MSI-H/ MMRd
NCT ID NCT05722327	TitlePhase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer	Fase Fase 1	Date Added 2023-02-10	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, Irinotecan, MRTX849	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05733611	TitleRP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC	Fase Fase 2	Date Added 2023-02-17	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT05684211	TitleUn estudio de ametumumab en combinación con un anticuerpo monoclonal anti-PD-1 y FOLFIRI en pacientes con cáncer colorrectal avanzado de tipo RAS salvaje	Fase Fase 2	Date Added 2023-01-13	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Ametumumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04117087	TitlePooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer	Fase Fase 1	Date Added 2019-10-07	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT04948034	TitleLa combinación de fruquintinib, tislelizumab y radioterapia ablativa estereotáctica en el cáncer colorrectal metastásico (RIFLE)	Fase Fase 2	Date Added 2021-07-01	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Fruquintinib, Tislelizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04607421	TitleA Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer (BREAKWATER)	Fase Fase 3	Date Added 2020-10-29	Ubicación Arizona, United States California, United States Florida, United States Illinois, United States Louisiana, United States Minnesota, United States Missouri, United States Nebraska, United States New Jersey, United States New York, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States Virginia, United States Washington, United States Wisconsin, United States Argentina Australia Bélgica Brasil Bulgaria Canadá China Czechia Dinamarca Finland Alemania India Italia Japón Corea, República de Mexico Países Bajos Nueva Zelanda Noruega Polonia Russian Federation Slovakia Sudáfrica España Suecia Taiwán Ukraine Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas 5-FU, Bevacizumab, capecitabine, cetuximab, encorafenib, Irinotecan, Leucovorin, oxaliplatin	Etiquetas MSS/ MMRp
NCT ID NCT02856425	TitleTrial Of Pembrolizumab And Nintedanib	Fase Fase 1	Date Added 2016-08-04	Ubicación Francia	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Nintedanib, Pembrolizumab, Keytruda, Ofev, Vargatef	Etiquetas MSS/ MMRp
NCT ID NCT04659382	TitleStudy to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2020-12-09	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Atezolizumab, Bevacizumab, TheraSphere, XELOX	Etiquetas MSS/ MMRp

Showing 181 to 190 of 299 entries